GlassScriptPhysician profile
Anuj Raj Kandel
NPI 1528222817
$2,946.61
in general payments reported to CMS, 2019-2025
22 companies · $1,225 in 2025
The $1,225 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $34.43 · 2021: $71.82 · 2022: $713 · 2023: $158 · 2024: $389 · 2025: $1,225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $1,000 · Food and Beverage: $772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $1,000.00 |
| Food and Beverage | $771.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,056.00 | 2025 | |
| Intuitive Surgical, INC. | $375.95 | 2019-2022 | |
| Tela Bio, INC. | $255.98 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Sirtex Medical INC | $251.59 | 2019-2022 | |
| Integra Lifesciences Corporation | $231.41 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Axonics, INC. | $149.81 | 2024 | Axonics |
| Pharmacosmos Therapeutics INC. | $115.42 | 2023 | Monoferric |
| Stryker Corporation | $100.31 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $84.09 | 2022-2025 | Exparel |
| Conmed Corporation | $45.45 | 2019 | |
| Kerecis Limited | $40.38 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Mallinckrodt Enterprises LLC | $32.79 | 2019 | |
| Acell, INC. | $28.99 | 2019-2020 | |
| Ethicon US, LLC | $28.48 | 2019-2021 | |
| Allergan, INC. | $28.19 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tetraphase Pharmaceuticals, INC. | $25.85 | 2019 | |
| Acera Surgical, INC. | $19.05 | 2025 | Restrata Wound Matrix |
| Covidien LP | $16.26 | 2019 | |
| Smith+Nephew, INC. | $15.82 | 2020 | |
| Braintree Laboratories, INC. | $15.65 | 2023 | Suflave |
| Baudax Bio INC. | $14.88 | 2021 | |
| Lsi Solutions INC | $14.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anuj Kandel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.